Lilly Endowment Inc Eli Lilly & CO Transaction History

Lilly Endowment Inc

$85.8 Trillion
Q3 2024

A detailed history of Lilly Endowment Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Lilly Endowment Inc holds 96,891,978 shares of LLY stock, worth $74.4 Billion. This represents 0.0% of its overall portfolio holdings.

Number of Shares

96,891,978

Previous 97,367,369 0.49%

Holding current value

$74.4 Billion

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$772.14 - $960.02 $367 Million - $456 Million	-475,391 Reduced 0.49%	96,891,978 $0
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $1.11 Billion - $1.39 Billion	-1,531,441 Reduced 1.55%	97,367,369 $0
Q1 2024 Apr 16, 2024	SELL	$592.2 - $792.28 $515 Million - $689 Million	-870,000 Reduced 0.87%	98,898,810 $0
Q4 2023 Jan 25, 2024	SELL	$525.19 - $619.13 $113 Million - $133 Million	-215,000 Reduced 0.22%	99,768,810 $0
Q3 2023 Oct 12, 2023	SELL	$434.7 - $599.3 $454 Million - $626 Million	-1,045,000 Reduced 1.03%	99,983,810 $0
Q2 2023 Jul 10, 2023	SELL	$350.74 - $468.98 $531 Million - $711 Million	-1,515,000 Reduced 1.48%	101,028,810 $0
Q1 2023 Apr 17, 2023	SELL	$310.63 - $364.82 $126 Million - $148 Million	-405,000 Reduced 0.39%	102,543,810 $0
Q4 2022 Jan 26, 2023	SELL	$321.55 - $374.67 $265 Million - $309 Million	-825,000 Reduced 0.79%	102,948,810 $0
Q3 2022 Oct 05, 2022	SELL	$296.48 - $337.87 $115 Million - $131 Million	-387,243 Reduced 0.37%	103,773,810 $33.6 Billion
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $556 Million - $652 Million	-1,993,133 Reduced 1.88%	104,161,053 $33.8 Billion
Q1 2022 Apr 19, 2022	SELL	$234.69 - $291.66 $307 Million - $382 Million	-1,309,624 Reduced 1.22%	106,154,186 $30.4 Billion
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $176 Million - $219 Million	-784,800 Reduced 0.72%	107,463,810 $29.7 Billion
Q3 2021 Oct 08, 2021	SELL	$221.6 - $272.71 $255 Million - $314 Million	-1,150,592 Reduced 1.05%	108,248,610 $25 Billion
Q2 2021 Jul 19, 2021	SELL	$180.55 - $233.54 $163 Million - $211 Million	-902,898 Reduced 0.82%	109,399,202 $25.1 Billion
Q1 2021 Apr 12, 2021	SELL	$164.32 - $212.72 $136 Million - $177 Million	-830,243 Reduced 0.75%	110,302,100 $20.6 Billion
Q3 2020 Oct 05, 2020	SELL	$146.22 - $169.13 $62.6 Million - $72.4 Million	-427,961 Reduced 0.38%	111,132,343 $16.4 Billion
Q2 2020 Jul 16, 2020	SELL	$136.42 - $164.18 $233 Million - $281 Million	-1,711,038 Reduced 1.51%	111,560,304 $18.3 Billion
Q1 2020 Apr 10, 2020	SELL	$119.05 - $147.35 $153 Million - $190 Million	-1,289,257 Reduced 1.13%	113,271,342 $15.7 Billion
Q4 2019 Jan 13, 2020	SELL	$106.92 - $132.43 $218 Million - $270 Million	-2,039,705 Reduced 1.75%	114,560,599 $15.1 Billion
Q3 2019 Oct 08, 2019	SELL	$106.79 - $116.16 $22.4 Million - $24.4 Million	-210,000 Reduced 0.18%	116,600,304 $13 Billion
Q1 2019 Apr 16, 2019	SELL	$111.31 - $131.02 $134 Million - $158 Million	-1,205,000 Reduced 1.02%	116,810,304 $15.2 Billion
Q4 2018 Jan 14, 2019	SELL	$105.9 - $118.64 $147 Million - $164 Million	-1,385,500 Reduced 1.16%	118,015,304 $13.7 Billion
Q3 2018 Oct 09, 2018	SELL	$85.86 - $107.31 $228 Million - $284 Million	-2,650,000 Reduced 2.17%	119,400,804 $12.8 Billion
Q2 2018 Jul 12, 2018	SELL	$75.7 - $86.88 $77.6 Million - $89.1 Million	-1,025,000 Reduced 0.83%	122,050,804 $10.4 Billion
Q4 2017 Jan 17, 2018	SELL	$81.94 - $87.89 $33.2 Million - $35.6 Million	-405,000 Reduced 0.33%	123,075,804 $10.4 Billion
Q3 2017 Oct 10, 2017	BUY	$77.07 - $85.54 $9.52 Billion - $10.6 Billion	123,480,804	123,480,804 $10.6 Billion

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lilly Endowment Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lilly Endowment Inc with notifications on news.

Account

Lilly Endowment Inc Eli Lilly & CO Transaction History